Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine

Title:Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine

Volume: 8 Issue: 2

Author(s): Ambikalmajan M.R. Pillai and Furn F. (Russ) Knapp

Affiliation:

Keywords: Antibodies, bone pain palliation, isotope production, Lutetium-177, peptides, targeted radionuclide therapy, therapeutic radiopharmaceuticals.

Abstract: Lutetium-177 (¹⁷⁷Lu) is a late entrant into the nuclear medicine therapy arena but is expected to become one of the most widely used therapeutic radionuclides. This paper analyses the reason for the increasing preference of ¹⁷⁷Lu as a therapeutic radionuclide. While the radionuclidic properties favor its use for several therapeutic applications, the potential for large scale production of ¹⁷⁷Lu is also an important aspect for its acceptability as a therapeutic radionuclide. This introductory discussion also summarizes some developing clinical uses and suggested future directions for applications of ¹⁷⁷Lu.

Cite this article as:

Pillai M.R. Ambikalmajan and (Russ) Knapp F. Furn, Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine, Current Radiopharmaceuticals 2015; 8 (2) . https://dx.doi.org/10.2174/1874471008666150312155959